Discusses Strategic Focus on Izicopan for ANCA-Associated Vasculitis and Renal Diseases May 8, 2026 8:30 AM EDTCompany ...

Thousands of times per year, a family’s moment of joy turns to unexpected grief. A seemingly healthy infant stops smiling or ...

Guggenheim Securities acted as lead bookrunner for the offering. Oppenheimer & Co. and LifeSci Capital also acted as bookrunners for the offering. Raymond James and Needham & Company acted as co-lead ...

For decades, Chinese hamster ovary (CHO) cells have been the gold standard for producing biologic drugs, from monoclonal ...

The immune system has become one of biotech's most important battlegrounds as drug developers race to target inflammatory ...

InflaRx intends to develop izicopan in ANCA-associated vasculitis (AAV), with a secondary goal of establishing rapid proof of concept in ...

Calorie restriction lowers C3, an immune protein tied to aging and inflammation, improving health without requiring weight ...

A revolutionary cancer treatment is now being applied to a wide range of autoimmune disorders. Columnist Michael Le Page ...

A new set of drugs exploit a recently-revealed weakness in 'zombie-like' – or senescent – cells that could lead to new treatments for cancer and age-associated diseases.

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) can have the same genetic cause, a discovery that won two neurogeneticists a portion of the 2026 Breakthrough Prize in Life Scienc ...

Welcome to Regeneron's conference call to discuss its C5 Complement Development Program. My name is Shannon, and I will be your operator for today's call. [Operator Instructions] Please note that this ...

Quantum computers—devices that process information using quantum mechanical effects—have long been expected to outperform classical systems on certain tasks. Over the past few decades, researchers ...